nano dexamethasone palmitate

Nano dexamethasone palmitate refers to nanoparticle-based formulations of the lipophilic prodrug dexamethasone palmitate. Dexamethasone palmitate is an esterified form of the corticosteroid dexamethasone, conjugated with palmitic acid to increase its hydrophobicity and facilitate encapsulation into nanocarriers such as solid lipid nanoparticles (SLNs), polymeric nanoparticles (e.g., PLGA-PEG), or liposomes[1][2][8]. These nanoformulations are designed for targeted delivery—especially via inhalation or intravenous routes—to inflamed tissues such as the lungs or joints. The mechanism of action is primarily through agonism of the glucocorticoid receptor in immune cells (notably alveolar macrophages), leading to potent anti-inflammatory effects by suppressing proinflammatory cytokines like TNF-α and IL-6[1][2]. Nanoformulations improve drug loading efficiency, stability during nebulization, and local tissue targeting while reducing systemic side effects compared to free dexamethasone[1][2][8]. They are under investigation for indications including pneumonia (especially pediatric pulmonary inflammation) and rheumatoid arthritis[1][2][7].

Other names

nano dexamethasone palmitatedexamethasone palmitate nanoparticlesDXMS-Pal-SLNsDXP-NPs